# Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects

> **NCT03657550** · PHASE1 · COMPLETED · sponsor: **Conjupro Biotherapeutics, Inc.** · enrollment: 36 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Levamlodipine, Amlodipine
- **DRUG:** Amlodipine, Levamlodipine

## Key facts

- **NCT ID:** NCT03657550
- **Lead sponsor:** Conjupro Biotherapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-31
- **Primary completion:** 2018-09-06
- **Final completion:** 2018-09-06
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2021-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03657550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03657550, "Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03657550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*